I-025

Interference Mix 3 (For Qualitative Use Only)

50-1000 μg/mL each component in acetonitrile, analytical standard, Cerilliant^®

• 別名: Qualitative Interference Mixture
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: analytical standard
• 品質水準: 100
• フォーム: liquid
• 組成: Aripiprazole, 100 μg/mL ; Lacosamide, 100 μg/mL ; Oxcarbazepine, 100 μg/mL ; (+)-Propoxyphene, 50 μg/mL ; Rufinamide, 100 μg/mL ; Warfarin, 1000 μg/mL
• 包装: ampule of 1 mL
• メーカー／製品名: Cerilliant^®
• drug control: estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• 濃度: 50-1000 μg/mL each component in acetonitrile
• テクニック: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• アプリケーション: forensics and toxicology
• フォーマット: multi-component solution
• 保管温度: −20°C

詳細

詳細

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• ピクトグラム: GHS02,GHS08,GHS07
• シグナルワード: Danger
• 危険有害性情報: H225,H302 + H312 + H332,H319,H360D,H373
• 注意書き: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P308 + P313
• 危険有害性の分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1A - STOT RE 2
• ターゲットの組織: Blood
• 保管分類コード: 3 - Flammable liquids
• WGK: WGK 2
• 引火点(°F): 35.6 °F - closed cup
• 引火点(℃): 2.0 °C - closed cup